EMJ GOLD: Pharma news, views and analysis · EMJ

S11 E04: The gender health divide: Driving change

·12 min·1 clip

20% of marketed drugs have clinically relevant sex differences in metabolism, yet trials aren't designed to detect them.

Host Isabelle O'Brien interviews pharmaceutical professional Carol about gender disparities in healthcare, focusing on underrepresentation of women in clinical trials, male bias in preclinical research, and how diversifying pharma leadership could improve drug development. The conversation covers concrete solutions like mandated sex-stratified analysis and looks ahead to AI's role in personalized medicine.

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from EMJ GOLD: Pharma news, views and analysis